Cisen Pharmaceutical Co., Ltd. (SHA:603367)
China
· Delayed Price · Currency is CNY 17.21
+0.30 (1.77%)
Mar 10, 2026, 3:00 PM CST
Cisen Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 649.16 | 1,161 | 983.39 | 997.95 | 938.98 | 661.42 | Upgrade
|
| Short-Term Investments | 490.38 | 357.58 | 154.11 | 236.27 | - | - | Upgrade
|
| Trading Asset Securities | 2,205 | 1,275 | 1,638 | 1,550 | 1,485 | 1,875 | Upgrade
|
| Cash & Short-Term Investments | 3,345 | 2,794 | 2,775 | 2,784 | 2,424 | 2,537 | Upgrade
|
| Cash Growth | 31.05% | 0.66% | -0.32% | 14.87% | -4.46% | 7.36% | Upgrade
|
| Accounts Receivable | 898.24 | 1,257 | 1,363 | 1,272 | 1,048 | 738.84 | Upgrade
|
| Other Receivables | 9.23 | 3.99 | 4.24 | 9.25 | 11.35 | 8.77 | Upgrade
|
| Receivables | 907.47 | 1,261 | 1,367 | 1,281 | 1,060 | 747.61 | Upgrade
|
| Inventory | 724.45 | 810.43 | 708.22 | 580.43 | 594.65 | 572.12 | Upgrade
|
| Other Current Assets | 211.38 | 97.1 | 119.41 | 99.63 | 66.45 | 93.84 | Upgrade
|
| Total Current Assets | 5,188 | 4,962 | 4,970 | 4,745 | 4,145 | 3,950 | Upgrade
|
| Property, Plant & Equipment | 1,699 | 1,546 | 1,390 | 1,489 | 1,591 | 1,637 | Upgrade
|
| Long-Term Investments | 5.51 | 665.48 | 602.27 | 265.08 | 308.01 | 246.59 | Upgrade
|
| Other Intangible Assets | 198 | 203.97 | 211.6 | 213.03 | 210.82 | 207.92 | Upgrade
|
| Long-Term Deferred Tax Assets | 70.83 | 77.41 | 79.83 | 86.72 | 81.65 | 63.12 | Upgrade
|
| Long-Term Deferred Charges | 0.69 | 0.47 | 1.91 | 3.86 | 2.05 | - | Upgrade
|
| Other Long-Term Assets | 459.01 | 98.74 | 81.94 | 12.87 | 25.54 | 61.09 | Upgrade
|
| Total Assets | 7,621 | 7,554 | 7,338 | 6,815 | 6,364 | 6,166 | Upgrade
|
| Accounts Payable | 711.15 | 549.49 | 468.01 | 459.71 | 434.97 | 502.13 | Upgrade
|
| Accrued Expenses | 81.45 | 114.89 | 139.77 | 259.48 | 214.52 | 219.74 | Upgrade
|
| Short-Term Debt | 11.94 | 71.98 | 34.8 | 57.79 | 130 | 330 | Upgrade
|
| Current Portion of Long-Term Debt | 7.41 | 32.63 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | 2.64 | 3.34 | 0.3 | 2.72 | - | Upgrade
|
| Current Income Taxes Payable | 34.8 | 11.71 | 34.67 | 5.61 | 1.18 | 8.24 | Upgrade
|
| Current Unearned Revenue | 59.08 | 78.11 | 100.16 | 118.78 | 70.05 | 70.53 | Upgrade
|
| Other Current Liabilities | 376.42 | 627.39 | 589.17 | 380.24 | 365.5 | 153.7 | Upgrade
|
| Total Current Liabilities | 1,282 | 1,489 | 1,370 | 1,282 | 1,219 | 1,284 | Upgrade
|
| Long-Term Debt | 21.37 | 7.7 | 128.5 | 100 | - | - | Upgrade
|
| Long-Term Leases | 2.34 | 0.89 | 4.03 | 0.51 | 10.91 | - | Upgrade
|
| Long-Term Unearned Revenue | 105.03 | 57.17 | 56.25 | 65.36 | 74.43 | 75.02 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 15.78 | 12.28 | 12.68 | 11.46 | 3.87 | 4.4 | Upgrade
|
| Total Liabilities | 1,427 | 1,567 | 1,571 | 1,459 | 1,308 | 1,364 | Upgrade
|
| Common Stock | 452.75 | 452.75 | 452.78 | 453.31 | 453.33 | 453.35 | Upgrade
|
| Additional Paid-In Capital | 1,935 | 1,929 | 1,919 | 1,913 | 1,863 | 1,844 | Upgrade
|
| Retained Earnings | 3,767 | 3,570 | 3,358 | 2,989 | 2,774 | 2,556 | Upgrade
|
| Treasury Stock | - | - | -0.08 | -19.77 | -32.74 | -50.49 | Upgrade
|
| Comprehensive Income & Other | -2.26 | -2.71 | -2.69 | -2.93 | -3.07 | -2.12 | Upgrade
|
| Total Common Equity | 6,153 | 5,950 | 5,727 | 5,332 | 5,055 | 4,801 | Upgrade
|
| Minority Interest | 41.28 | 37.39 | 39.1 | 23.64 | 0.75 | 1 | Upgrade
|
| Shareholders' Equity | 6,194 | 5,987 | 5,766 | 5,356 | 5,056 | 4,802 | Upgrade
|
| Total Liabilities & Equity | 7,621 | 7,554 | 7,338 | 6,815 | 6,364 | 6,166 | Upgrade
|
| Total Debt | 43.06 | 115.83 | 170.67 | 158.61 | 143.63 | 330 | Upgrade
|
| Net Cash (Debt) | 3,302 | 2,678 | 2,604 | 2,625 | 2,280 | 2,207 | Upgrade
|
| Net Cash Growth | 33.54% | 2.81% | -0.79% | 15.15% | 3.32% | -2.48% | Upgrade
|
| Net Cash Per Share | 7.24 | 5.89 | 5.75 | 5.78 | 5.05 | 4.88 | Upgrade
|
| Filing Date Shares Outstanding | 452.75 | 452.75 | 452.76 | 451.36 | 449.83 | 447.8 | Upgrade
|
| Total Common Shares Outstanding | 452.75 | 452.75 | 452.76 | 451.34 | 449.83 | 447.8 | Upgrade
|
| Working Capital | 3,906 | 3,473 | 3,600 | 3,463 | 2,926 | 2,666 | Upgrade
|
| Book Value Per Share | 13.59 | 13.14 | 12.65 | 11.81 | 11.24 | 10.72 | Upgrade
|
| Tangible Book Value | 5,955 | 5,746 | 5,516 | 5,119 | 4,844 | 4,593 | Upgrade
|
| Tangible Book Value Per Share | 13.15 | 12.69 | 12.18 | 11.34 | 10.77 | 10.26 | Upgrade
|
| Buildings | - | 1,277 | 1,275 | 1,188 | 1,191 | 975.57 | Upgrade
|
| Machinery | - | 2,109 | 2,092 | 1,903 | 1,797 | 1,494 | Upgrade
|
| Construction In Progress | - | 405.8 | 66.68 | 207.17 | 199.71 | 582.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.